ELISA-based competitive trypsin inhibition assay

Proteolytic enzymes are crucial for numerous biological processes and are tightly controlled by specific inhibitors. In addition to the research activities to investigate the natural effects of these inhibitors, it is important to determine the inhibition capabilities of inhibitors due to their impo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bengü Ergenoğlu, Özlem Ertekin, Şerife Şeyda Pirinçci Göktürk, Göknur Gizem Dinç, Esin Akçael, Melahat Bağirova, Fatıma Yücel
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/474c2071fa1f4d9caf3f323e4a181613
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:474c2071fa1f4d9caf3f323e4a181613
record_format dspace
spelling oai:doaj.org-article:474c2071fa1f4d9caf3f323e4a1816132021-11-17T14:21:55ZELISA-based competitive trypsin inhibition assay1310-28181314-353010.1080/13102818.2021.1977697https://doaj.org/article/474c2071fa1f4d9caf3f323e4a1816132021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/13102818.2021.1977697https://doaj.org/toc/1310-2818https://doaj.org/toc/1314-3530Proteolytic enzymes are crucial for numerous biological processes and are tightly controlled by specific inhibitors. In addition to the research activities to investigate the natural effects of these inhibitors, it is important to determine the inhibition capabilities of inhibitors due to their importance in different fields, including food and health industry. In this study, we describe a high-throughput adaptable screening method to detect inhibitors and compare their inhibition efficiency at nanogram levels, using a Competitive enzyme-linked immunosorbent assay (ELISA) based Trypsin Inhibition Assay (E-CTIA). We worked with four different inhibitors from different sources and action mechanisms, all of which were competitive inhibitors. The half-maximal inhibitory concentration (IC50) strongly correlated with the experimental inhibition capacities introduced in the user manuals. E-CTIA successfully fulfills the requirements of an assay, such as reproducibility, low cost, low sample requirement and ease of use. It also enables to test multiple samples simultaneously in a short time, and it has the potential to be adapted to bigger plate formats such as 384 well or even bigger. Besides being the first successful example of Competitive ELISA Based Inhibition Assay, it has the potential to be used for many competitive inhibitors.Bengü ErgenoğluÖzlem ErtekinŞerife Şeyda Pirinçci GöktürkGöknur Gizem DinçEsin AkçaelMelahat BağirovaFatıma YücelTaylor & Francis Grouparticletrypsin inhibitionic50 inhibition efficiencyelisaBiotechnologyTP248.13-248.65ENBiotechnology & Biotechnological Equipment, Vol 35, Iss 1, Pp 1385-1392 (2021)
institution DOAJ
collection DOAJ
language EN
topic trypsin inhibition
ic50
inhibition efficiency
elisa
Biotechnology
TP248.13-248.65
spellingShingle trypsin inhibition
ic50
inhibition efficiency
elisa
Biotechnology
TP248.13-248.65
Bengü Ergenoğlu
Özlem Ertekin
Şerife Şeyda Pirinçci Göktürk
Göknur Gizem Dinç
Esin Akçael
Melahat Bağirova
Fatıma Yücel
ELISA-based competitive trypsin inhibition assay
description Proteolytic enzymes are crucial for numerous biological processes and are tightly controlled by specific inhibitors. In addition to the research activities to investigate the natural effects of these inhibitors, it is important to determine the inhibition capabilities of inhibitors due to their importance in different fields, including food and health industry. In this study, we describe a high-throughput adaptable screening method to detect inhibitors and compare their inhibition efficiency at nanogram levels, using a Competitive enzyme-linked immunosorbent assay (ELISA) based Trypsin Inhibition Assay (E-CTIA). We worked with four different inhibitors from different sources and action mechanisms, all of which were competitive inhibitors. The half-maximal inhibitory concentration (IC50) strongly correlated with the experimental inhibition capacities introduced in the user manuals. E-CTIA successfully fulfills the requirements of an assay, such as reproducibility, low cost, low sample requirement and ease of use. It also enables to test multiple samples simultaneously in a short time, and it has the potential to be adapted to bigger plate formats such as 384 well or even bigger. Besides being the first successful example of Competitive ELISA Based Inhibition Assay, it has the potential to be used for many competitive inhibitors.
format article
author Bengü Ergenoğlu
Özlem Ertekin
Şerife Şeyda Pirinçci Göktürk
Göknur Gizem Dinç
Esin Akçael
Melahat Bağirova
Fatıma Yücel
author_facet Bengü Ergenoğlu
Özlem Ertekin
Şerife Şeyda Pirinçci Göktürk
Göknur Gizem Dinç
Esin Akçael
Melahat Bağirova
Fatıma Yücel
author_sort Bengü Ergenoğlu
title ELISA-based competitive trypsin inhibition assay
title_short ELISA-based competitive trypsin inhibition assay
title_full ELISA-based competitive trypsin inhibition assay
title_fullStr ELISA-based competitive trypsin inhibition assay
title_full_unstemmed ELISA-based competitive trypsin inhibition assay
title_sort elisa-based competitive trypsin inhibition assay
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/474c2071fa1f4d9caf3f323e4a181613
work_keys_str_mv AT benguergenoglu elisabasedcompetitivetrypsininhibitionassay
AT ozlemertekin elisabasedcompetitivetrypsininhibitionassay
AT serifeseydapirinccigokturk elisabasedcompetitivetrypsininhibitionassay
AT goknurgizemdinc elisabasedcompetitivetrypsininhibitionassay
AT esinakcael elisabasedcompetitivetrypsininhibitionassay
AT melahatbagirova elisabasedcompetitivetrypsininhibitionassay
AT fatımayucel elisabasedcompetitivetrypsininhibitionassay
_version_ 1718425477695143936